Company wins prestigious accolade for its Risk-Based Monitoring Software at the 2014 Scrip Awards
We are delighted to announce that CluePoints won the Scrip Award 2014 for the “Best Technological Development in Clinical Trials” with its Risk-Based Monitoring in the Cloud! Many thanks to all our customers, supporters and colleagues for helping CluePoints to be so successful. This award is for you all!
4 December 2014
Cambridge, MA – CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials, was honoured with the award for the ‘Best Technological Development in Clinical Trials’ at the 2014 Scrip Awards held at The Lancaster Hotel, London on 3 December. The award, sponsored by the MCT Congress, recognizes ‘CluePoints in the Cloud’ as the ultimate quality oversight and risk-based monitoring (RBM) application developed to determine the quality and integrity of clinical trials data.
With customers already able to utilise CluePoints’ CSM solution as a service, the company has been continually working to enhance the usability of its platform to meet the industry’s current needs and taking into consideration the feedback from its clients. In particular the need for a solution that enables companies to take full control of their own RBM activities using all the data within their clinical databases. In response, CluePoints launched a solution to enable customers to drive their own analyses through a new web platform. Taking away the need for processes to be solely overseen by a separate organisation, the solution puts the management of RBM processes firmly in the hands of sponsors and CROs.
“It is an honour to receive an award that recognises the value of our CSM solution developed to empower sponsors and CROs to objectively and independently determine both the quality and integrity of their trial data”, says Franҫois Torche, CEO of CluePoints. “I would like to extend continual thanks to all our customers and of course the CluePoints’ team who developed this award-winning first-of-its-kind cloud-based platform.”
Company’s Central Statistical Monitoring Solution recognized in the ‘Best Technological Development in Clinical Trials’ category
24 September 2014
Cambridge, MA – CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials, has been shortlisted as a finalist in the ‘Best Technological Development in Clinical Trials’ category for the 2014 Scrip Awards. The category recognizes the fundamental importance of using the most sophisticated platforms to catalyze and optimize data gathered during clinical trials. Winners chosen by a panel of experts from around the world will be announced at a gala in London on 3 December.
CluePoints has been acknowledged for its unique Central Statistical Monitoring (CSM) software that enables sponsors and CROs to objectively and independently determine the quality of their clinical trial data. The first-of-its-kind cloud-based architecture provides an effective and pragmatic solution to risk-based monitoring (RBM) that puts users in complete control of their own analyses. This enables them to manage the upload of clinical data for assessment, visualize the findings and interact with analyses to make the understanding of results, comprehension of signals and identification of issues as intuitive as possible. As a result, users now have the ability to independently identify anomalies in data earlier, offering the opportunity to eradicate issues as they are uncovered and achieving higher quality data throughout the entirety of a trial.
“We are delighted that the Scrip Awards judges have recognized the value of the CluePoints’ CSM solution in putting sponsors and CROs in full control of determining the quality and integrity of their clinical trial data”, says Franҫois Torche, CEO of CluePoints. “When we set out to develop the platform, we did so with a view of making RBM analyses practical and accessible, taking away the need for processes to be solely overseen by a separate organization and putting the management of RBM activities firmly in the hands of those running the clinical trial.”
For further information on CluePoints’ solutions, please visit www.CluePoints.com
CluePoints® is a Central Statistical Monitoring solution that has been designed and perfected over the last 10 years. It employs unique statistical algorithms to determine the quality, accuracy and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the FDA and EMA, CluePoints® is deployed to support traditional on-site monitoring and to drive a risk-based monitoring strategy. The value of using CluePoints® lies in its powerful and timely ability to identify anomalous data and site errors allowing improvement in clinical data quality, optimization of on-site monitoring and a significant reduction in overall regulatory submission risk.
Patrick Hughes – Chief Commercial Officer, CluePoints
+44 (0) 7703 532 749